Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 5
Submit an article Journal homepage
2,281
Views
0
CrossRef citations to date
0
Altmetric
Acceptance – Commentary

Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt

Ashata Dahala Patan Academy of Health Sciences, Oxford University Clinical Research Unit-Nepal, Lalitpur, NepalCorrespondence[email protected]
,
Mila Shakyaa Patan Academy of Health Sciences, Oxford University Clinical Research Unit-Nepal, Lalitpur, Nepal
,
Dikshya Pantb Department of Paediatrics, Patan Academy of Health Sciences, Lalitpur, Nepal
,
Anup Adhikaric Nepal Family Development Foundation, Lalitpur, Nepal
,
Rachel Colin-Jonesd Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK
,
Katherine Theiss-Nylandd Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK
,
Andrew J. Pollardd Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK
,
Buddha Basnyata Patan Academy of Health Sciences, Oxford University Clinical Research Unit-Nepal, Lalitpur, Nepal
&
Shrijana Shresthab Department of Paediatrics, Patan Academy of Health Sciences, Lalitpur, Nepal
 show all
Article: 2043104 | Received 23 Nov 2021, Accepted 14 Feb 2022, Published online: 03 Mar 2022

References

  • Meiring JE, Sambakunsi R, Moyo E, Misiri T, Mwakiseghile F, Patel P, Patel P, Ndaferankhande J, Laurens M, Gooding K, et al. Community engagement before initiation of typhoid conjugate vaccine trial in schools in two urban townships in Blantyre, Malawi: experience and lessons. Clin Infect Dis. 2019;68(2 Suppl):S146–5. doi:10.1093/cid/ciy1110.
  • Shakya M, Colin-Jones R, Theiss-Nyland K, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, et al. Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal. N Engl J Med. 2019;381(123):2209–18. doi:10.1056/NEJMoa1905047.
  • Karkey A, Aryjal A, Basnyat B, Baker S. Kathmandu, Nepal: still an enteric fever capital of the world. J Infect Dev Ctries. 2005;2(6):461–65. doi:10.3855/jidc.162.
  • Colin-Jones R, Shakya M, Voysey M, Theiss-Nyland K, Smith N, Pant D, Liu X, Tonks S, Mazur O, Farroq YG, et al. Logistics of implementing a large-scale typhoid vaccine trial in Kathmandu, Nepal. Clin Infect Dis. 2019;68(2 Suppl):S138–S145. doi:10.1093/cid/ciy1125.
  • Patel P, Patel P, Meiring M, Misiri T, Mwakiseghile F, Gordon MA. Stories from the field on the ground in Malawi—first typhoid conjugate vaccine study in Africa. Am J Trop Med Hyg. 2019;100(6):1299–300. doi:10.4269/ajtmh.19-0014.
  • Shakya M, Voysey M, Theiss-Nyland K, Colin-Jones R, Pant D, Adhikari A, Tonks S, Mujadidi YF, O’-Reilly P, Mazur O, et al. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomized, controlled trial. Lancet Glob Health. 2021;9(11):E1561–E1568. doi:10.1016/S2214-109X(21)00346-6.
  • Ibnas M, Asim M, Mekkodathil A, Sathian B. Practical challenges and obligations for conducting clinical trial in Nepal: a call for improvement. NEPJOL 2019;9(3):769–71. doi:10.3126/nje.v9i3.25804.
  • Basu S, Lurie P. Correspondence hepatitis E vaccine. N Engl J Med. 2007;356(23):2421–22. doi:10.1056/NEJMc070884.
  • McNair S. A shot to change the world: an analysis of process and partnership in U.S. military vaccine research [ Doctoral dissertation]. Boston (USA): Harvard Medical School; 2015.
  • Mills EJ, Singh S. Health, human rights, and the conduct of clinical research within oppressed populations. Global Health. 2007;3(10). doi:10.1186/1744-8603-3-10.
  • Andrews J. Research in the ranks: vulnerable subjects, coercible collaboration, and the hepatitis E vaccine trial in Nepal. Perspect Biol Med. 2006;49(1):35–51. doi:10.1353/pbm.2006.0001. PMID: 16489275.
  • Sahay S, Kumar M, Srikrishnan AK, Ramanathan V, Mahendale S. Experiences in recruiting volunteers through community-based initiatives in Phase-1 vaccine trials in India. Hum Vaccin Immunother. 2014;10(2):485–91. doi:10.4161/hv.26799.
  • Adhikari RK, Sherchand JB, Mishra SR, Ranabhat K, Wagle RR. Awareness and coverage of mass drug administration for elimination of Lymphatic Filariasis: a community based cross sectional study in Nepal. J Community Health. 2014;40(1):34–40. doi:10.1007/s10900-014-9891-1.
  • Qamar FN, Batool R, Qureshi S, Ali M, Sadaf T, Mehmood J, Iqbal K, Sultan A, Duff N, Yousafzai MT. Strategies to improve coverage of typhoid conjugate vaccine (TCV) immunization campaign in Karachi, Pakistan. Vaccines (Basel). 2020;8(697):1–12. doi:10.3390/vaccines8040697.
  • Musesengwa R, Chimbari MJ. Experiences of community members and researchers on community engagement in an ecohealth project in South Africa and Zimbabwe. BMC Med Ethics. 2017;18(76):1–15. doi:10.1186/s12910-017-0236-3.
  • Adhikari B, Pell C, Cheah PY. Community engagement and ethical global health research. Global Bioethics. 2020;31(1):1–12. doi:10.1080/11287462.2019.1703504.
  • Ahmad T, Haroon H, Ahmad K, Shah SM, Shah MW, Hussain A, Jalal S, Ahmad W, Khan M, Harapan H, et al. Hepatitis E vaccines: a mini review. Biomed Res Ther. 2021;8(9):4514–24. doi:10.15419/bmrat.v8i9.690.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.